At a glance
Small molecule high throughput screen using AstraZeneca facilities is a national competitive grant from UK Research and Innovation for the research & development sector. Eligible applicants: See the official UKRI opportunity page; eligibility varies by council and call - most require UK-based researchers or organisations. The application deadline is September 9, 2026. Apply via the official listing at www.ukri.org.
- Amount
- See listing
- Deadline
- Sep 9, 2026
- Type
- Competitive
- Status
- Closing soon
About this program
Funding opportunity Funding opportunity: Small molecule high throughput screen using AstraZeneca facilities Opportunity status: Open Funders: Medical Research Council (MRC) Funding type: Grant Total fund: £1,000,000 Maximum award: £270,000 Publication date: 30 January 2026 Opening date: 30 January 2026 9:00am UK time Closing date: 9 September 2026 4:00pm UK time Last updated: 20 May 2026 - see all updates Start application Apply for funding to run a high throughput screen (HTS) using AstraZeneca’s compound library and screening robots. There are two funding opportunities per year, which remain open to all targets. Who can apply To lead a project, you must be based at an eligible organisation. Check if your organisation is eligible . Who is eligible to apply To be eligible to apply for this funding opportunity you must show that you will direct the project and be actively engaged in the w...
Who can apply
See the official UKRI opportunity page; eligibility varies by council and call - most require UK-based researchers or organisations.
How to apply
Apply through the UKRI Funding Service as directed on the official opportunity page linked below.
Apply at official source